Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis
E Álvarez-Hernández, I Peláez-Ballestas, A Boonen… - Reumatologia clinica, 2012 - Elsevier
BACKGROUND: The cost of certain diseases may lead to catastrophic expenses and
impoverishment of households without full financial support by the state and other …
impoverishment of households without full financial support by the state and other …
Validation of the Health Assessment Questionnaire disability index in patients with gout
E Álvarez‐Hernández… - Arthritis Care & …, 2008 - Wiley Online Library
Objective To assess the psychometric properties of the Health Assessment Questionnaire
(HAQ) disability index (DI) in patients with gout. Methods This study was conducted in a …
(HAQ) disability index (DI) in patients with gout. Methods This study was conducted in a …
Current smoking status is associated to a non-ACR 50 response in early rheumatoid arthritis. A cohort study
J Rojas-Serrano, LL Pérez, CG García… - Clinical …, 2011 - Springer
The purpose of this study is to determine factors associated with a non-ACR 50 response at
6 months of follow-up, in a cohort of patients with early rheumatoid arthritis (RA). Early RA …
6 months of follow-up, in a cohort of patients with early rheumatoid arthritis (RA). Early RA …
Update of the Mexican College of Rheumatology guidelines for the pharmacologic treatment of rheumatoid arthritis
MH Cardiel, A Díaz-Borjón… - … Clínica (English Edition), 2014 - Elsevier
Background The pharmacologic management of rheumatoid arthritis has progressed
substantially over the past years. It is therefore desirable that existing information be …
substantially over the past years. It is therefore desirable that existing information be …
COVID-19 vaccine hesitancy among Mexican outpatients with rheumatic diseases
G Guaracha-Basáñez, I Contreras-Yáñez… - Human Vaccines & …, 2021 - Taylor & Francis
Vaccine hesitancy (VH) has emerged as a recognized threaten to contain the COVID-19
pandemic. Historically, low vaccine acceptance rates had been described among patients …
pandemic. Historically, low vaccine acceptance rates had been described among patients …
[HTML][HTML] Prevalence of complementary and alternative medicine despite limited perceived efficacy in patients with rheumatic diseases in Mexico: Cross-sectional study
CI Caballero-Hernández, SA González-Chávez… - Plos one, 2021 - journals.plos.org
Introduction Complementary and alternative medicine (CAM) is frequently used by patients
with rheumatic diseases (RD) to improve their symptoms; however, its diversity and …
with rheumatic diseases (RD) to improve their symptoms; however, its diversity and …
Clinical practice guidelines for the treatment of systemic lupus erythematosus by the Mexican College of Rheumatology
D Xibillé-Friedmann, M Pérez-Rodríguez… - … Clínica (English Edition), 2019 - Elsevier
There are national and international clinical practice guidelines for systemic lupus
erythematosus treatment. Nonetheless, most of them are not designed for the Mexican …
erythematosus treatment. Nonetheless, most of them are not designed for the Mexican …
[HTML][HTML] The COVID-19 epidemic curve and vaccine acceptance among patients with rheumatic diseases: an ecological study
A Gastelum-Strozzi, DE Flores-Alvarado… - Rheumatology …, 2023 - Springer
The attitudes toward emerging COVID-19 vaccines have been of great interest worldwide,
especially among vulnerable populations such as patients with rheumatic and …
especially among vulnerable populations such as patients with rheumatic and …
Pan-American League of Associations for Rheumatology (PANLAR) capillaroscopy study group consensus for the format and content of the report in capillaroscopy in …
C Bertolazzi, A Vargas Guerrero… - Clinical …, 2019 - Springer
Objective The aim of this work was to produce a consensus-based report for capillaroscopy
in rheumatology to be used in daily clinical practice. Methods A written Delphi questionnaire …
in rheumatology to be used in daily clinical practice. Methods A written Delphi questionnaire …
Are target urate and remission possible in severe gout? A five-year cohort study
C Alvarado-de la Barrera, CO López-López… - The Journal of …, 2020 - jrheum.org
Objective. Determine the proportion of patients achieving target serum urate (SU), defined
as< 6 mg/dl for patients with non-severe gout and< 5 mg/dl for patients with severe gout, as …
as< 6 mg/dl for patients with non-severe gout and< 5 mg/dl for patients with severe gout, as …